BIOGEN (DENMARK) A/S: Financial statements 2017
CVR: 21682977
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BIOGEN (DENMARK) A/S (CVR 21682977) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 349,466,112 and a net result of DKK 9,095,758 compared with DKK 12,980,189 the year before. That is a decrease of 10.9% compared with the year before. The profit margin was 2.6%. Equity in the 2017 report amounted to DKK 79,532,934. The solvency ratio was 51.5%. The company had 29 employees in the financial year.
- Revenue
- DKK 349,466,112
- Gross Profit
- DKK 63,024,464
- Profit/Loss
- DKK 9,095,758
- Equity
- DKK 79,532,934
- Total Assets
- DKK 154,521,018
- Employees
- 29
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 349.5 mio. | 63 mio. | 9.1 mio. | 79.5 mio. | 29 |
| 2016 | 392.1 mio. | 59.4 mio. | 13 mio. | 70.4 mio. | 26 |
| 2015 | 298.4 mio. | 74.4 mio. | 9.1 mio. | 57.5 mio. | 29 |
| 2014 | 297.9 mio. | 84.2 mio. | 8.1 mio. | 48.4 mio. | 26 |
| 2013 | 204.9 mio. | 64.9 mio. | 5.6 mio. | 40.3 mio. | 25 |
Official annual report
Keep an eye on BIOGEN (DENMARK) A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of July 10, 2017, Ulf Johan Ström has joined the board of directors of BIOGEN (DENMARK) A/S.
As of July 10, 2017, Vesna Leskovsek Cizej has left the board of directors of BIOGEN (DENMARK) A/S.
BIOGEN (DENMARK) A/S has published its annual report for 2016. Revenue came to DKK 392,113,116, and the net result was DKK 12,980,189.
About BIOGEN (DENMARK) A/S
BIOGEN (DENMARK) A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1999. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BIOGEN IDEC (DENMARK) A/S. The management consists of Erik Magnus Bodin. The board consists of Neil Raymond Sisak (chair), Allan Frank Fischer Petersen, Erik Magnus Bodin and Sergio Ferreira da Silva Teixeira. The company is owned by Biogen Netherlands B.V.. The company has 20 employees (2018). In 2025, the company reported revenue of DKK 178,728,185 and a net result of DKK 5,563,672 compared with DKK 7,526,703 the year before. Equity in the 2025 report amounted to DKK 151,886,117.